Bright Minds Biosciences (DRUG) Current Leases (2022 - 2026)
For the quarter ending Q1 2026, Current Leases changed N/A year-over-year to $59889.7, compared with a TTM value of $59889.7 through Mar 2026, changed N/A, and an annual FY2025 reading of $61421.0, up 5.55% over the prior year.
Bright Minds Biosciences (DRUG) has disclosed Current Leases for 5 consecutive years, with $59889.7 as the latest value for Q1 2026.
- Current Leases reached $59889.7 in Q1 2026 per DRUG's latest filing, down from $61421.0 in the prior quarter.
- Across five years, Current Leases topped out at $61421.0 in Q3 2025 and bottomed at $52083.5 in Q3 2022.
- Average Current Leases over 5 years is $57289.9, with a median of $58192.7 recorded in 2024.
- Year-over-year, Current Leases increased 5.34% in 2023 and then grew 6.07% in 2024.
- Bright Minds Biosciences' Current Leases stood at $52083.5 in 2022, then rose by 5.34% to $54862.4 in 2023, then increased by 6.07% to $58192.7 in 2024, then rose by 5.55% to $61421.0 in 2025, then dropped by 2.49% to $59889.7 in 2026.
- Per Business Quant, the three most recent readings for DRUG's Current Leases are $59889.7 (Q1 2026), $61421.0 (Q3 2025), and $58192.7 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 720.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Bright Minds Biosciences | 464.72 Mn | 405.19 Mn | - | 59,889.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,889.66 |
| Dec 31, 2025 | 63,215.46 |
| Sep 30, 2025 | 61,421.00 |
| Jun 30, 2025 | 56,429.26 |
| Mar 31, 2025 | 54,185.26 |
| Dec 31, 2024 | 52,017.18 |
| Sep 30, 2024 | 58,192.71 |
| Jun 30, 2024 | 10,247.67 |
| Mar 31, 2024 | 25,775.08 |
| Dec 31, 2023 | 40,078.46 |
| Sep 30, 2023 | 54,862.44 |
| Jun 30, 2023 | 57,614.67 |
| Mar 31, 2023 | 54,433.52 |
| Dec 31, 2022 | 51,505.85 |
| Sep 30, 2022 | 52,083.54 |